US Importation & Drug Shortages

Government of Canada Comments on Drug Shortages and the Importation of Drugs from the United States
The Government of Canada comments on the Food and Drug Administration Proposed Rule on 'Importation of Prescription Drugs' (Docket No. FDA-2019-N-5711 ), identified as Pathway 1 in the Safe Importation Action Plan.
Comment from Government of Canada
 

CAPDM Position Statement on Drug Shortages and the Importation of Drugs from the United States
CAPDM Position Statement on US Drug Importation

Canadian Multi-Stakeholder Response to Proposed Rulemaking titled "Importation of Prescription Drugs,'' Docket No. FDA-2019-N-5711
Canadian Multi-Stakeholder Response to Importation of Prescription Drugs

December 18, 2019
Canada drug supply 'insufficient'
"The drug supply is insufficient for the Canadian market, let alone trying to divert it to a much larger market like the U.S.," said Daniel Chiasson, president of the Canadian Association for Pharmacy Distribution Management, a trade group that represents drug distributors. "We're not supportive of any policy initiative or policy proposal that has the capacity to threaten the stability of medications available to Canadians." READ Full CBC Report